Dergiler / Medicine Science / 2019 / Cilt: 8 - Sayı: 3

Oxidative metabolism and urotensin-II levels among bipolar disorder patientsin a manic episode

Sayfa
703–709
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Our study is the first one to examine relationship between U-II levels and oxidative parameters in manic episode of bipolar disorder; therefore, it may significantly contribute to the literature.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:According to the previous studies, it has been noted many times that oxidative balance is disrupted in bipolar disorder.
📊
Temel Bulgular & Veri:In this study, we aimed to investigate the relationship between U-II levels and oxidative metabolism among bipolar disorder patients in the manic episode.Forty-two patients diagnosed as bipolar disorder manic episode according to DSM-5 and 55 healthy controls enrolled in the study.
💡
Sonuç & Katkı:Our study is the first one to examine relationship between U-II levels and oxidative parameters in manic episode of bipolar disorder; therefore, it may significantly contribute to the literature.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

According to the previous studies, it has been noted many times that oxidative balance is disrupted in bipolar disorder. However, we did not found any research investigating the relationship between Urotensin-II (U-II) levels and oxidative metabolism among bipolar disorder patients in the literature. In this study, we aimed to investigate the relationship between U-II levels and oxidative metabolism among bipolar disorder patients in the manic episode.Forty-two patients diagnosed as bipolar disorder manic episode according to DSM-5 and 55 healthy controls enrolled in the study. Serum total antioxidant status (TAS), total oxidant status (TOS), nitric oxide (NO), U-II and oxidative stress index (OSI) measurements were done in the biochemistry laboratory of Gaziantep University. When TAS, TOS, OSI, NO, and U-II levels were compared between bipolar disorder manic episode patients and control group; TAS, TOS, OSI, NO and U-II levels were significantly higher in the patient group than the control group (p=0.003, p=0.001, p=0.001, p=0.001 and p=0.009 respectively). According to the correlation analysis, U-II levels were found to have a weak linear correlation in the positive direction with TOS and OSI (r=0.326, p=0.035 for TOS; and r=0.369, p=0.016 for OSI). In the earlier studies, data have been obtained about the effects of U-II on behavior, sleep, inflammatory system and oxidative metabolism and relevant hypotheses have been established. In the light of these studies in the literature, our study proposes that increased U-II levels could be a factor affecting the elevated oxidative stress and inflammation in patients with bipolar disorder manic episode. Our study is the first one to examine relationship between U-II levels and oxidative parameters in manic episode of bipolar disorder; therefore, it may significantly contribute to the literature.

🔖

Bu Makaleye Atıf Yap

DEMİR, B., ALPAK, G. (2019). Oxidative metabolism and urotensin-II levels among bipolar disorder patientsin a manic episode. Medicine Science, Cilt: 8 - Sayı: 3, 703–709. https://ajindex.com/articles/277026

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Akkaya C, Deniz G, CAngür S, et al. The relationship between the duration of drug use and the bipolar disorder patients’ sociodemographic and clinical characteristics. Turk Psikiyatri Derg. 2014;25:94-105
  2. Andreazza AC, Cassini C, Rosa AR, et al. Serum S100B and antioxidant enzymes in bipolar patients. J Psychiatr Res. 2007;41:523-9
  3. Steckert AV, Valvassori SS, Moretti M, et al. Role of oxidative stress in the pathophysiology of bipolar disorder. Neurochem Res. 2010;35:1295-301
  4. Selek S, Savas HA, Gergerlioglu HS, et al. The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode. J Affect Disord. 2008;107:89-94
  5. Savas HA, Gergerlioglu HS, Armutcu F, et al. Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes. World J Biol Psychiatry. 2006;7:51-5
  6. Erdem M, Akarsu S, Pan E, et al. Bipolar disorder and oxidative stress. Psychiatr Behavioral Sci. 2014;4:70-9
  7. Onan D, Hannan RD, Thomas WG. Urotensin II: The old kid in town. Trends Endocrinol. Metab. 2004;15:175-82
  8. Hunt BD, Leong LN, Lambert DG. A rat brain atlas of urotensin-II receptor expression and a review of central urotensin-II effects. Naunyn-Schmied Arch Pharmacol. 2010;382:1–31
  9. Bulbul F, Alpak G, Unal A, et al. New molecule in the etiology of schizophrenia: Urotensin II. Psychiatr Clin Neurosci. 2014;68:133–6
  10. Gartlon J, Parker F, Harrison DC et al. Central effects of urotensin-II following ICV administration in rats. Psychopharmacology (Berl). 2001;155:426–33
  11. Huitron-Resendiz S, Kristensen MP, Sanchez-Alavez M, et al. Urotensin II modulates rapid eye movement sleep through activation of brainstem cholinergic neurons. J Neurosci. 2005;25:5465–74
  12. Osman Hasan Tahsin Kilic, Ihsan Aksoy, Gulcin Cinpolat Elboga, et al. Oxidative parameters, oxidative DNA damage, and urotensin-II in schizoaffective disorder patients. Psychiatr Clin Psychopharmacol. 2019;29:151-7
  13. Oral E, Halici Z, Cinar I, et al. Evaluation of Endothelial Dysfunction in Bipolar Affective Disorders: Serum Endocan and Urotensin-II Levels. Clin Psychopharmacol Neurosci. 2019;17:211–21
  14. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clinical Biochemistry. 2004;37:112-9
  15. Erel O. A new automated colorimetric method for measuring total oxidant status. Clinical biochemistry. 2005;38:1103-11
  16. Yumru M, Savas HA, Kalenderoglu A, et al. Oxid